2 ICORG Studies published in leading Oncology Journals this month

ICORG has 2 first author papers published in leading journals this month – Journal of Clinical Oncology & Annals of Oncology.

ICORG 07-08 {A randomised Phase III study of Sunitinib in combination with Capecitebine compared with Capecitebine in patients with previously treated breast cancer. [Pfizer A6181099] } has been published in the Journal of Clinical Oncology. Click here for link

ICORG 06-04 {An open-label, multicenter, Phase I/II dose escalation study of oral lapatinib in combination with docetaxel (Taxotere) plus trastuzumab (Herceptin) in subjects previously untreated for ErbB2-overexpressing metastatic breast cancer. [GSK EGF100161] } has been published in the Annals of Oncology. Click here for link

Leave a comment